Affiliation:
1. Department of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER) – Guwahati Changsari Kamrup, Assam 781101 India
2. Department of Neurology School of Medicine National and Kapodistrian University of Athens, Eginition Hospital 11528 Athens Greece
3. Department of Biological Chemistry Medical School National and Kapodistrian University of Athens Athens 11527 Greece
Abstract
AbstractBiochanin A, an isoflavone flavonoid with estrogenic activity, is naturally found in red clover and other legumes. It possesses a wide range of pharmacological properties, including antioxidant, anti‐inflammatory, anti‐apoptotic, neuroprotective, and anticancer effects. In recent years, a growing body of pre‐clinical research has focused on exploring the therapeutic potential of biochanin A in various neurological disorders, such as Alzheimer's and Parkinson's disease, multiple sclerosis, epilepsy, ischemic brain injury, gliomas, and neurotoxicity. This comprehensive review aims to shed light on the underlying molecular mechanisms that contribute to the neuroprotective role of biochanin A based on previous pre‐clinical studies. Furthermore, it provides a detailed overview of the protective effects of biochanin A in diverse neurological disorders. The review also addresses the limitations associated with biochanin A administration and discusses different approaches employed to overcome these challenges. Finally, it highlights the future opportunities for translating biochanin A from pre‐clinical research to clinical studies while also considering its commercial viability as a dietary supplement or a potential treatment for various diseases.